Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells.
about
Bacteria in Cancer Therapy: Renaissance of an Old ConceptSpontaneous regression of tumour and the role of microbial infection--possibilities for cancer treatmentSalmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growthThe tumor-educated-macrophage increase of malignancy of human pancreatic cancer is prevented by zoledronic acid.Salmonella as an innovative therapeutic antitumor agent.Tumor-targeting Salmonella typhimurium A1-R prevents experimental human breast cancer bone metastasis in nude mice.Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models.Inhibition of spontaneous and experimental lung metastasis of soft-tissue sarcoma by tumor-targeting Salmonella typhimurium A1-RTumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis.Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models.Tumor-Targeting Salmonella typhimurium A1-R Arrests a Chemo-Resistant Patient Soft-Tissue Sarcoma in Nude Mice.Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.Intraperitoneal administration of tumor-targeting Salmonella typhimurium A1-R inhibits disseminated human ovarian cancer and extends survival in nude mice.Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model.Salmonella Bacterial Monotherapy Reduces Autochthonous Prostate Tumor Burden in the TRAMP Mouse ModelTumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapyAttenuated mutant strain of Salmonella Typhimurium lacking the ZnuABC transporter contrasts tumor growth promoting anti-cancer immune response.Tumor-targeting Salmonella typhimurium A1-R inhibits human prostate cancer experimental bone metastasis in mouse models.Therapeutic efficacy of tumor-targeting Salmonella typhimurium A1-R on human colorectal cancer liver metastasis in orthotopic nude-mouse modelsAdjuvant treatment with tumor-targeting Salmonella typhimurium A1-R reduces recurrence and increases survival after liver metastasis resection in an orthotopic nude mouse model.Salmonella overcomes tumor immune tolerance by inhibition of tumor indoleamine 2, 3-dioxygenase 1 expressionTumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model.Salmonella VNP20009-mediated RNA interference of ABCB5 moderated chemoresistance of melanoma stem cell and suppressed tumor growth more potently.Tumor-specific cell-cycle decoy by Salmonella typhimurium A1-R combined with tumor-selective cell-cycle trap by methioninase overcome tumor intrinsic chemoresistance as visualized by FUCCI imaging.Angiogenic inhibitors delivered by the type III secretion system of tumor-targeting Salmonella typhimurium safely shrink tumors in mice.High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model.Solid tumors provide niche-specific conditions that lead to preferential growth of Salmonella.Salmonella inhibits tumor angiogenesis by downregulation of vascular endothelial growth factor.Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model.High-efficacy targeting of colon-cancer liver metastasis with Salmonella typhimurium A1-R via intra-portal-vein injection in orthotopic nude-mouse models.Methods for the development of tumor-targeting bacteria.Treating cancer with infection: a review on bacterial cancer therapy.Antimelanoma effect of Salmonella Typhimurium integration host factor mutant in murine model.Tumor-targeting Salmonella typhimurium A1-R regresses an osteosarcoma in a patient-derived xenograft model resistant to a molecular-targeting drug.Utilizing Salmonella to treat solid malignancies.Toxicology and efficacy of tumor-targeting Salmonella typhimurium A1-R compared to VNP 20009 in a syngeneic mouse tumor model in immunocompetent mice.Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma.Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide.Tumor-Targeting Salmonella typhimurium A1-R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic-Cancer Orthotopic Mouse Model.
P2860
Q26751222-D61186D9-6711-493F-A9F3-6922C5A1785EQ26774238-55DB5AF9-54E5-4EBD-8A23-0E41EC8FD115Q33798724-27D031E5-4593-4075-8D84-78890215073BQ34035071-AF2AF837-4960-49C6-9751-D76498F1D2BFQ34158653-9FE3F5A9-BF2B-4BB2-A6A8-5E2926CFF45DQ34334522-18FBD0EF-A84F-4781-8A8E-A7CAC45588DCQ35067893-ED3930CE-025F-4939-81DA-7CAD571CE22CQ35149573-47F9F5D5-A8FB-4948-8911-F597DEE8C9C7Q35550049-491EAEA6-CB18-474C-9A2A-814B61A53E94Q35654559-BD828AD8-6293-4176-A104-3CC56E86E742Q35735164-03A16789-E8CF-42B1-A0C7-E789D90703C1Q35766493-7F5A854A-0435-4E40-843C-F69B215F19C2Q35793808-99F98B45-97A8-4984-99A1-A4D35F1FE4CEQ36097450-2CEB1D7D-CCBB-41D6-AEA2-3CD52AA61F62Q36098726-FEA2EC39-90C7-4CCB-9A04-E693F61BAF74Q36189385-26B1971F-AEED-43CF-9838-79CAC7E536F7Q36232119-9910F995-067F-4057-89EE-4E47B014467DQ36544572-891EED78-38D0-47B0-9C5C-0D2ABBB0CE11Q36544581-851C540D-9500-4890-872A-02A9E8A31F80Q36561606-1401D4B7-34A9-4861-A898-A0F94F9BB4C9Q36729425-1A367282-7773-4F89-A622-FE6F5C16D574Q37022286-5560A944-CA93-4A85-A127-5235E9E7FCC9Q37046756-DA9D1985-A3E5-4DD1-A0F0-65433030EB09Q37118741-DF44BF68-6B4A-41BF-B7B1-D732401821B4Q37201418-64F01302-25F8-4C8C-AC6A-BA1244D2DA8FQ37362834-F4FC0441-253F-4CD1-9E77-B68104E043B3Q37376492-95FE5449-C4EF-48B0-9238-E6CF23B1B5F7Q37437201-417CEA90-45F7-4D68-B7EA-C503306AF5DFQ37699156-DB49BE12-8B7B-4FB8-81E0-D722CCEF8435Q37745932-E20C86CD-2C16-47B7-8024-3953E1C285FDQ38221907-EC959529-554E-4E19-A25E-07964555FBF3Q38473938-7C559F7B-13EC-4E7F-A1BA-CA6F853E59C7Q38850160-A7A78690-EA69-48E9-8300-0041937A6425Q39057954-756CD5CC-F0E5-46C0-935A-1065F1B579CDQ39248906-ED55722C-D2EB-4945-BC32-3BB613BAB866Q41551244-F2F601B2-0A8A-4C46-8A6E-A213A9303E2BQ41661119-67A1DCD8-4618-4ECD-A002-52CD0B911A5FQ44538901-A87D5820-B523-4F9C-821E-0CCED04F0C20Q46020823-334170EC-0F30-41B3-858C-53860DA0E952Q46115870-5C9E412A-8FB1-401B-A1A3-BD8548B2AE43
P2860
Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of efficacy of Salm ...... human pancreatic cancer cells.
@en
Comparison of efficacy of Salm ...... human pancreatic cancer cells.
@nl
type
label
Comparison of efficacy of Salm ...... human pancreatic cancer cells.
@en
Comparison of efficacy of Salm ...... human pancreatic cancer cells.
@nl
prefLabel
Comparison of efficacy of Salm ...... human pancreatic cancer cells.
@en
Comparison of efficacy of Salm ...... human pancreatic cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of efficacy of Salm ...... human pancreatic cancer cells.
@en
P2093
Atsushi Suetsugu
Fuminari Uehara
Itaru Endo
Kuniya Tanaka
Masashi Momiyama
Michael Bouvet
Mohamed K Hassanein
Robert M Hoffman
P2860
P304
P356
10.4161/CC.25872
P577
2013-08-06T00:00:00Z